FI955261A0 - Antikroppar mot P-sekektin och deras användning - Google Patents
Antikroppar mot P-sekektin och deras användningInfo
- Publication number
- FI955261A0 FI955261A0 FI955261A FI955261A FI955261A0 FI 955261 A0 FI955261 A0 FI 955261A0 FI 955261 A FI955261 A FI 955261A FI 955261 A FI955261 A FI 955261A FI 955261 A0 FI955261 A0 FI 955261A0
- Authority
- FI
- Finland
- Prior art keywords
- selectin antibodies
- antibodies
- selectin
- activated
- leukocytes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1993/004274 WO1993021956A1 (en) | 1992-05-05 | 1993-05-04 | Antibodies to p-selectin and their uses |
US5729293A | 1993-05-05 | 1993-05-05 | |
US08/202,047 US5800815A (en) | 1903-05-05 | 1994-02-25 | Antibodies to P-selectin and their uses |
PCT/US1994/004935 WO1994025067A1 (en) | 1993-05-04 | 1994-05-04 | Antibodies to p-selectin and their uses |
Publications (2)
Publication Number | Publication Date |
---|---|
FI955261A0 true FI955261A0 (sv) | 1995-11-02 |
FI955261A FI955261A (sv) | 1996-01-03 |
Family
ID=27369213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI955261A FI955261A (sv) | 1993-05-04 | 1995-11-02 | Antikroppar mot P-sekektin och deras användning |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0804235A4 (sv) |
FI (1) | FI955261A (sv) |
WO (1) | WO1994025067A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6155896A (en) * | 1995-06-07 | 1996-12-30 | Cytel Corporation | Humanized antibodies to e-selectin |
AU6390696A (en) * | 1995-06-20 | 1997-01-22 | Trustees Of Boston University | Hypoxia-responsive adhesion molecules, specific antibodies, nd their uses |
WO1999018442A1 (en) * | 1997-10-07 | 1999-04-15 | Centocor, Inc. | Diagnosis of thrombotic events by detecting p-selectin |
AU2012200852B2 (en) * | 2004-04-13 | 2012-10-18 | F. Hoffmann-La Roche Ag | Anti-P-selectin antibodies |
PL1737891T3 (pl) * | 2004-04-13 | 2013-08-30 | Hoffmann La Roche | Przeciwciała przeciw selektynie p |
US8945565B2 (en) | 2006-12-01 | 2015-02-03 | Selexys Pharmaceuticals Corporation | Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies |
US20110212096A1 (en) | 2006-12-01 | 2011-09-01 | Scott Rollins | Anti-p-selectin antibodies and methods of their use and identification |
PT2662091T (pt) | 2006-12-01 | 2018-12-03 | Novartis Ag | Anticorpos anti-p-selectina e métodos para os utilizar no tratamento de doenças inflamatórias |
WO2009046978A1 (en) * | 2007-10-12 | 2009-04-16 | F. Hoffmann-La Roche Ag | Protein expression from multiple nucleic acids |
WO2019025847A1 (en) | 2017-08-04 | 2019-02-07 | Novartis Ag | TREATMENT DIAGRAMS |
KR20210003086A (ko) | 2018-03-08 | 2021-01-11 | 노파르티스 아게 | 항-p-셀렉틴 항체의 용도 |
WO2020247698A1 (en) | 2019-06-07 | 2020-12-10 | Novartis Ag | Use of an anti-p-selectin antibody |
EP4010019A1 (en) | 2019-08-08 | 2022-06-15 | Novartis AG | Use of the anti-p-selectin antibody crizanlizumab for treating sickle cell nephropathy and chronic kidney disease associated with sickle cell disease |
EP4213878A4 (en) * | 2020-09-16 | 2024-07-03 | Univ Ramot | METHODS OF TREATMENT OF GLIOBLASTOMA |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL162181A (en) * | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
CA2067250C (en) * | 1989-10-20 | 2008-06-17 | Bruce Furie | Inhibition of padgem-mediated cell binding |
EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
AU681850B2 (en) * | 1992-05-05 | 1997-09-11 | Aeres Biomedical Limited | Antibodies to P-selectin and their uses |
-
1994
- 1994-05-04 WO PCT/US1994/004935 patent/WO1994025067A1/en not_active Application Discontinuation
- 1994-05-04 EP EP94917301A patent/EP0804235A4/en not_active Withdrawn
-
1995
- 1995-11-02 FI FI955261A patent/FI955261A/sv not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0804235A4 (en) | 2001-09-19 |
WO1994025067A1 (en) | 1994-11-10 |
FI955261A (sv) | 1996-01-03 |
EP0804235A1 (en) | 1997-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI955261A0 (sv) | Antikroppar mot P-sekektin och deras användning | |
ES2102196T3 (es) | Periferializacion de celulas pluripotenciales hematopoyeticas. | |
PT833911E (pt) | Anticorpos anti-factor tecidular enxertados com cdr e metodos para a sua utilizacao | |
ATE249518T1 (de) | Humanisierter antikörper gegen cd18 | |
PT730608E (pt) | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes | |
ATE439137T1 (de) | Behandlung von hämatologischen störungen | |
MX9602971A (es) | Anticuerpos humanizados contra la molecula vla-4 de adhesion de leucocitos. | |
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
ID29393A (id) | Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
FI941826A (sv) | Förfaranden och kompositioner för profylaktisk och/eller terapeutisk behandling av ett organs hypofunktion | |
DE69128543T2 (de) | Monoklonale antikörper der maus | |
SE8605295D0 (sv) | Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes | |
DE60229406D1 (de) | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) | |
GB9009106D0 (en) | Processes and intermediates for synthetic antibody derivatives | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
ATE283044T1 (de) | Compactin zur behandlung von entzündungen | |
GR3018304T3 (en) | Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones. | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
AU6633694A (en) | Novel methods and compositions for the treatment of (ras)-activated cancer with heterotypic anti-(raf) antisense oligonucleotides | |
CA2162149A1 (en) | Antibodies to p-selectin and their uses | |
GR3031095T3 (en) | 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION. | |
EA199800821A1 (ru) | Способ лечения аутизма | |
Kelsey | An audit of the use of platelet concentrates in the prophylaxis of thrombocytopenic haemorrhage in a large haematology unit | |
ES2122034T3 (es) | Difosfatos de catecolaminas y composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |